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Physical exercise  and  probucol  decreased  plasma  cholesterol  levels  in  LDLr−/− mice.
Physical exercise  mitigates  the  spatial  memory  deﬁcits  of  LDLr−/− mice.
Probucol did  not  mitigate  the  spatial  memory  deﬁcits  of LDLr−/− mice.
Exposure to  EE  did  not  mitigate  the  spatial  memory  deﬁcits  of  adult  LDLr−/− mice.
Exposure to  EE  induced  persistent  anxyolitic-like  effects  in  LDLr−/− mice.
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Epidemiological  studies  indicate  that  high  midlife  plasma  cholesterol  levels  increases  the  risk  of
Alzheimer’s  disease.  Moreover,  middle-aged  familial  hypercholesterolemia  (FH)  subjects  show  a  particu-
larly  high  incidence  of  mild  cognitive  impairments  (MCI).  These  evidence  points  to  hypercholesterolemia
as  one  of the  modiﬁable  risk  factors  focused  on prevention/treatment  of cognitive  deterioration.
The  present  study  draws  a comparison  between  pharmacological  (lipid-lowering  drug  probucol)  and
non-pharmacological  (voluntary  running  wheel,  RW)  approaches  for the  management  of  hypercho-
lesterolemia  and  cognitive  impairments  associated  with  the  low-density  lipoprotein  receptor-deﬁcient
(LDLr−/−)  mice,  a well-established  rodent  model  of  FH.  We  also  investigated  whether  exposure  to  environ-
mental  enrichment  (EE),  a feasible  option  to  increase  physical  activity  in  young  mice cohort,  from  birth  to
adolescence  (PN45)  yields  long-term  behavioral  changes  in  adult  LDLr−/− mice (PN90).  We  observed  that
−/−nvironmental enrichment both  probucol  and  RW  signiﬁcantly  decreased  total  and  non-HDL  plasma  cholesterol  levels  in  LDLr
mice.  Notably,  only  physical  exercise  mitigated  the spatial  memory  deﬁcits  of LDLr−/− mice.  In  addition,
we  showed  that  exposure  to EE  from  birth  until  the  adolescence  did  not  mitigate  the  spatial  memory
deﬁcits  of  adult  LDLr−/− mice  in  the  object  location  task,  although  it induced  persistent  anxyolitic-like
effects  in  the  open  ﬁeld  arena.  Collectively,  our  results  emphasize  the  advantages  physical  exercise,  in
comparison  to lipid-lowering  drugs,  for the  management  of  cognitive  deﬁcits  associated  with  FH.. IntroductionFamilial hypercholesterolemia (FH) is an inherited metabolic
isorder characterized by high levels of plasma low-density
ipoproteins (LDL) [12]. Nowadays, with a prevalence of about one
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in 500 individuals, FH remains the most common monogenic disor-
der of lipoprotein metabolism, and it is mainly due to mutations in
the LDL receptor (LDLr) gene that leads to the plasma accumulation
of cholesterol ester-laden LDL particles [21]. Accordingly, famil-
ial hypercholesterolemia (FH) patients with defective LDLr display
high plasma levels of LDL cholesterol and are at signiﬁcant risk of
developing cardiovascular disease [3].
Open access under the Elsevier OA license.While hypercholesterolemia has been recognized for decades
as a potential risk factor for cardiovascular disease development,
recent studies have indicated an association between cholesterol
dyshomeostasis and the pathophysiology of sporadic Alzheimer’s
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isease (AD) [7]. Epidemiological studies have shown that hyper-
holesterolemia is an early risk factor for AD [30], and patients
ith FH – which are exposed to higher cholesterol levels from
arly life – may  be recognized as a potential high-risk group
or cognitive decline. Interestingly, middle age patients with FH
how a particularly high incidence of mild cognitive impairments
MCI) [35], corroborated by an experimental model of FH, the
poB100/LDLr−/− mouse strain [27].
Taken together, these evidence points to hypercholesterolemia
s one of the modiﬁable risk factors focused on preven-
ion/treatment of cognitive deterioration. Pharmacological [14] and
on-pharmacological [18] approaches have been used with rela-
ive success to manage dyslipidemias. However, contraindications
nd adverse effects of pharmacotherapy raise interest in non-
harmacological management of diseases, such as physical exercise
r diet, not only to improve health, but also the welfare and quality
f life.
The present study emphasizes physical exercise as intervention
trategy against cognitive impairments [1] associated with FH. Vol-
ntary running wheel (RW) was used to assess activity-mediated
holesterol lowering and/or behavior in mature mice, and envi-
onmental enrichment (EE) was used to increase activity in young
ice cohort. Moreover, we drew a comparison between physi-
al exercise (voluntary running wheel, RW)  and a lipid-lowering
rug (probucol) for the management of hypercholesterolemia
nd  cognitive impairments associated with FH. To address the
forementioned questions regarding hypercholesterolemia, phys-
cal exercise and cognitive performance, we used the low-density
ipoprotein receptor-deﬁcient (LDLr−/−) mice, a well-established
odent model of FH [34].
.  Methods
.1. Animals
LDL receptor knockout (LDLr−/−) mice founders were purchased
rom Jackson Laboratory (Bar Harbor, ME), breed at Universidade
ederal de Santa Catarina (Florianópolis, Brazil), and maintained
nder standard conditions of light (12-h light cycle, on 7:00 AM),
nd temperature (23 ± 1 ◦C). These animals display constitutive
ncreased plasma levels of cholesterol (2–3×) in low fat diet condi-
ions/standard [15], as used here (NUVILAB, Nuvital, Paraná, Brazil).
nimals had free access to food and water. All efforts were made
o minimize the number and suffering of animals. The procedures
sed in the present study complied with the guidelines on animal
are of the UFSC Ethics Committee on the Use of Animals, which
ollows the “Principles of Laboratory Animal Care” from NIH.
.2.  Experimental design
.2.1.  Experiment 1
Twenty-six-weeks-old male LDLr−/− mice were individually
oused in cages with free access to running (G1) (RW 4½′′, Super
et, USA) or locked wheels (G2) (not spinning), this last to avoid
nvironmental bias. These wheels remained in the same cage place
o avoid spatial enrichment. At same time, half of animals of G1
nd G2 were treated with the lipid-lowering drug probucol. Probu-
ol (Sigma, St. Louis, MO,  USA) was added in drinking water in a
nal concentration of 17.5 mg/L, providing a dose of approximately
.5 mg/kg/day for each animal. The duration of probucol treatment
nd exposure to running wheels (RW) lasted four weeks. After this
eriod, animals were evaluated in the object location task (N = 9–10
nimals per group). After the performance of the cognitive tasks,
nimals were food-deprived overnight and the blood was collected Letters 541 (2013) 193– 198
in  heparinized tubes from the heart to determine the total choles-
terol and non-HDL-cholesterol levels.
2.2.2. Experiment 2
Brieﬂy,  LDLr−/− timed pregnant mice were randomly assigned
to the standard or enriched environment (EE) group 4–7 days prior
to delivery. The EE-rearing protocol used was  based on the previ-
ously described by Simonetti et al. [29]. One dam and its litter were
placed in standard control cages (30 cm ×13 cm ×13 cm), while
two dams with a combined litter size of 10 pups or more were
placed in EE cages (45 cm ×30 cm ×13 cm). The EE contained many
additional objects (a running wheel, plastic tubing, rubber balls,
scented plush balls and a bell-ball). Items were moved to different
locations within each cage every 2–3 days. Both male and female
pups were used in roughly equal proportions. Mice assigned to the
EE group received enrichment until adolescence (postnatal day 45,
PN45). The dams were housed in the EE during the weaning period
(i.e. from birth to PN21), and then they were withdrawn from the
EE and the male and female pups were changed to independent
EE cages. On the postnatal day 90, animals were evaluated in the
object location task (N = 8 animals per group).
2.3. Behavioral test
2.3.1.  Object location task
The  spatial memory of mice was assessed with the object loca-
tion task. The task is based on the spontaneous tendency of rodents,
previously exposed to two  identical objects, to later explore one of
the objects – replaced in a novel location – for a longer time than
they explore the non-displaced object, and has been used for the
evaluation of hippocampal-dependent memories [2].
The  experimental apparatus used in this study was an open-ﬁeld
box, made of transparent PVC, with a white ﬂoor of 50 cm ×50 cm
(divide by black lines into 25 squares of 10 cm × 10 cm), and trans-
parent walls with 40-cm high. The apparatus was  placed in a
dimly lit and sound-isolated room. Identical plastic rectangles
(4 cm high × 4.5 cm wide) were used as objects. The mice were
placed in the center of the apparatus with two identical objects
for 5 min. The objects were placed 7 cm away from the walls of
the open ﬁeld. Exploration of the objects was recorded by a stop-
watch when mice sniffed, whisked, or looked at the objects from
no more than 1 cm away. After the training phase, the mice were
removed from the apparatus for 180 min. After the inter-trial inter-
val, one object was moved to a new location. The time spent
by the animals exploring the objects in new (displaced) and old
(familiar/non-displaced) locations were recorded during 5 min. All
locations of the objects were counterbalanced among the groups.
To analyze the cognitive performance of mice, a location index
was calculated: (Tdisplaced × 100)/(Tdisplaced + Tnon-displaced),
where Tdisplaced is the time spent exploring the displaced object
and Tnon-displaced is the time spent exploring the non-displaced
object [2].
2.4.  Plasma lipids levels
The  animals were food-deprived overnight, and whole blood
was collected from the heart, immediately centrifuged at 1000 × g
and the plasma frozen at −80 ◦C. Total cholesterol (TC), HDL-
cholesterol and triglycerides (TGs) were measured in plasma using
the enzymatic kit according to the manufacturer’s instructions
(Gold Analisa Diagnóstica Ltda, Minas Gerais, Brazil). The concen-
tration of non-HDL-cholesterol was  calculated using the equation:
(LDL + VLDL + IDL) = TC − HDL.
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Fig. 1. Effects of probucol and RW on plasma lipid levels, cognitive, locomotor and anxiety-related behaviors in LDLr−/− mice. Experimental design (A). Probucol and RW
decreased plasma total cholesterol (B) and non-HDL cholesterol levels (C), while not affected HDL cholesterol (D) and triglycerides levels (E). No differences were observed
between groups on the acquisition trial of the object location task (F). RW improves the recognition index of LDLr−/− mice in the test trial of the object location task (G),
and reduces anxiety-related behaviors in the open ﬁeld arena (H and I). Data are expressed as mean ± SEM. *P < 0.05 compared to control sedentary LDLr−/− mice; #P < 0.05
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.5. Statistical analyzes
Data  are expressed as mean ± S.E.M. The object location task
as analyzed by one-sample t-tests to determine whether the
ocation index was different from chance performance (50%). The
est of statistical analyses were carried out using unpaired t-tests
r a two-way analysis of variance (ANOVA). Following signiﬁcant
NOVAs, multiple post hoc comparisons were performed using the
ewman–Keuls test. The accepted level of signiﬁcance for all tests
as P ≤ 0.05. All tests were performed using the STATISTICA® soft-
are package (StatSoft Inc, Tulsa, OK, USA).
. Results
.1. Experiment 1
In  accordance with previous studies [23,28], we  observed the
ipid-lowering effects of probucol and physical exercise. Two-way
NOVA indicated main effects for RW by probucol interaction [F(1,
5) = 8.76, P ≤ 0.05] for total plasma cholesterol levels. Moreover,
igniﬁcant effects of their interaction [F(1, 15) = 11.30, P ≤ 0.05]
ere detected for non-HDL cholesterol levels. Subsequent post
oc comparisons revealed a signiﬁcant decrease in plasma lev-
ls of total and non-HDL cholesterol in LDLr−/− mice submitted
o RW and/or probucol treatment when compared to control
edentary LDLr−/− mice (P ≤ 0.05) (Fig. 1B and C). Meanwhile, RWhoc test). &P < 0.05 versus chance level (50% of displaced object investigation in test
and/or  probucol treatment did not alter the plasma HDL choles-
terol and triglycerides levels when compared to the control group
(Fig. 1D and E).
Previously, we  depicted the effects of the absence of the LDL
receptor on learning and memory functions using LDLr−/− mice and
wild-type littermates [6,24]. Speciﬁcally, we evaluated the short-
term spatial memory of mice using an object location task, which
provides a qualitative index (i.e. the animals discriminate or not the
object location change). Noteworthy, the wild-type C57Bl/6 mice
showed a location index signiﬁcantly higher than chance perfor-
mance, while LDLr−/− mice were not able to identify the spatial
alteration in the open ﬁeld arena [6,24]. Thus, in the current study
we sought to evaluate whether pharmacological (probucol) or non
pharmacological (RW) lipid-lowering strategies would improve the
cognitive impairments of LDLr−/− mice in the object location task.
Interestingly, in the present study we show that only physical exer-
cise mitigates the cognitive impairments of LDLr−/− mice. LDLr−/−
mice submitted to RW explored for a longer time the moved object,
as indicated by a signiﬁcant increase in location index in compar-
ison with chance performance [t = 6.004 (plus water) and t = 6.849
(plus probucol); P < 0.05] (Fig. 1G).
Moreover,  two-way ANOVA indicated a signiﬁcant effect of RW
for total crossings [F(1, 35) = 17.93, P ≤ 0.05] and percentage of cen-
tral crossings [F(1, 35) = 10.48, P ≤ 0.05] in the open ﬁeld arena.
Subsequent post hoc comparisons indicated that exercised mice
(regardless of probucol treatment) displayed decreased exploration
196 E.L.G.  Moreira et al. / Neuroscience Letters 541 (2013) 193– 198
Fig. 2. Effects of EE from birth until adolescence (PN45) on cognitive, locomotor and anxiety-related behaviors in adult male and female LDLr−/− mice (PN90). Experimental
design (A). No differences were observed between groups on the acquisition trial of the object location task (B). EE fails to improve the recognition index of LDLr−/− mice in
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nd increased central locomotion when compared to sedentary
ice (P ≤ 0.05) (Fig. 1H and I).
.2.  Experiment 2
Herein  EE was used as a feasible option to increase physi-
al activity in young mice cohort. However, when we  investigate
he role of EE (from birth until adolescence, PN45) in the spa-
ial cognitive impairment of adult male and female LDLr−/− mice
PN90), we observed no improvements (Fig. 2C). On the other
and, EE signiﬁcantly increased the central locomotion of male
t = 3.16, P ≤ 0.05) and female (t = 3.23, P ≤ 0.05) adult LDLr−/− mice
Fig. 2E), although no signiﬁcant differences in total locomotion
ere observed between groups. Despite the lipid-lowering effects
f physical exercise, our experimental protocol allowed for a
5-days interval between the end of EE exposure and the measur-
ng of plasma cholesterol levels; hence, plasma cholesterol levels
eturned to basal levels in the LDLr−/− mice (data not shown).
.  Discussion
In recent years, several lines of evidence have linked progressive
eterioration of cholesterol homeostasis and the pathophysiology
f sporadic AD [7,31]. Epidemiological studies suggest that high
idlife total plasma cholesterol levels increases the risk of both AD
nd vascular dementia (VaD) [30]. Interestingly, FH subjects show
 particularly high incidence of mild cognitive impairments (MCI)
35]. These observations, combined with the fact that hypercho-
esterolemia induces neuroinﬂammation [31], brain mitochondrial
ysfunction [6] and oxidative stress [4], raises the question as to
hether lipid-lowering agents, i.e. statins, could be useful as pre-
entive or therapeutic agents for AD? However, previous clinical
tudies have been contradictory, with some reports showing no
eneﬁt of statins on the progression of symptoms in individualsE). Data are expressed as mean ± SEM. *P < 0.05 compared to control LDLr−/− mice
with  mild to moderate AD [9], while others have reported substan-
tial improvements [10].
On  the other hand, life-style changes such as physical exer-
cise also improve age-related cognitive impairments by enhancing
synaptic plasticity [1,22], including neurogenesis and increased
neuronal survival in the hippocampus [33], capillary growth and
increased vascular ﬂow in cerebellum and motor cortex [17],
and enhancement of hippocampal-dependent learning and mem-
ory [32]. Moreover, regular exercise can prevent, delay, or even
reverse the progression of atherosclerosis and development of
coronary artery disease [11]. Thus, we sought to draw a compar-
ison between pharmacological and non-pharmacological methods
for the management of hypercholesterolemia and cognitive impair-
ments associated with FH.
Our results indicated that both pharmacological and non-
pharmacological strategies similarly decreased the total and
non-HDL plasma cholesterol levels in LDLr−/− mice, an animal
model of FH [34]. Although the underlying mechanisms whereby
probucol lowers LDL remains uncertain, there is experimen-
tal evidence that probucol increases LDL turnover by increasing
lipoprotein clearance without altering synthesis [26]. On the other
hand, the lipid-lowering properties of exercise are associated with
increased cholesterol turnover, owing to increased fecal bile acid
excretion and decreased intestinal cholesterol absorption in mice
[23]. As a result, one may  posit that the association of both strate-
gies might potentiate their lipid-lowering effects. Surprisingly, we
did not observe additive interactions between exercise and probu-
col in LDLr−/− mice. Further studies are required to determine the
impacts of the association of exercise and probucol in LDLr−/− mice
fed with a high cholesterol diet.
Despite the lipid-lowering effects of both strategies, herein
we provide evidence that only exercise mitigated the cogni-
tive impairments observed in hypercholesterolemic LDLr−/− mice
[6,24]. These data indicate that simply lowering plasma choles-
terol levels with a lipid-lowering drug may  not be sufﬁcient to
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ounteract the cognitive impairments associated with FH. Con-
ersely, the beneﬁcial effects of exercise on cognitive impairments
f LDLr−/− mice might be related to its well-established cognitive
nhancer effects, rather than a consequence of its lipid-lowering
roperties in LDLr−/− mice. Noteworthy, regular exercise prevents
he development of coronary artery disease [16] and is associated
ith a reduced risk of AD [5]. Thus, the performance of additional
ongitudinal studies to verify whether physical exercise can mod-
late the development of MCI  associated with FH appears to be
mportant.
On the other hand, the lipid-lowering effects of probucol were
nable to mitigate the cognitive impairments of LDLr−/− mice, sug-
esting that the dysfunction of LDLr contributes to the cognitive
mpairments of LDLr−/− mice. Indeed, the LDLr appears to play
n important role in maintaining normal hippocampal cell prolif-
ration and synapse formation [25], and either early exposure to
levated plasma cholesterol levels or LDLr dysfunction contributes
o cognitive decline in FH patients [35]. Interestingly, other mem-
ers of the LDLr family have been investigated more extensively in
he CNS and have been related to neuronal migration during devel-
pment [13]. The fact that FH subjects are also inﬂuenced by the
onsequences of defective LDLr during development is notewor-
hy; hence it would be of interest to investigate the role of LDLr on
rain development and its relation with the recently established
ssociation between FH and MCI.
Herein we aimed to determine whether physical exercise per-
ormed speciﬁcally during the ﬁrst weeks of the postnatal period,
hich is characterized by a signiﬁcant CNS development, would
revent/attenuate the cognitive impairments observed in the adult
DLr−/− mice. In order to achieve this goal, the animals were sub-
itted to EE during the ﬁrst six postnatal weeks. Accordingly, EE
epresents a feasible option to increase the levels of physical activ-
ty in pups, which affects lifelong learning ability and reinforces
he importance of early postnatal experiences on cognitive devel-
pment [29]. Speciﬁcally, early exposure to enriched conditions
an lead to increases in brain weight, cortical thickness, dendritic
ranching, synaptic density, and changes in the regulation of neu-
al plasticity [8,19]. Functionally, EE results in an improvement of
ognitive capabilities, accompanied by enhancement of markers of
ynaptic plasticity and transmission [20].
Herein we examined whether exposure to EE from birth to
dolescence (PN45) yields long-term behavioral changes in adult
DLr−/− mice (PN90). Our results show enduring anxyolitic-like
ffects of EE in LDLr−/− mice, thus illustrating the effectiveness
f our EE paradigm. Nonetheless, here we showed that exposure
o EE until the adolescence did not mitigate the spatial memory
eﬁcits of adult LDLr−/− mice in the object location task. These ﬁnd-
ngs are in contradistinction to previous work that showed that
arly experience has a life-long impact on performance of com-
lex learning tasks [29]. Taking into account that previous studies
oint to reduced neuronal plasticity in the LDLr−/− mice owing to
he decreased availability of cholesterol uptake by neurons [25], it
s reasonable to posit that the LDLr−/− mice requires regular and
ontinuous manipulations of synaptic plasticity (i.e. exercise) to
ounteract its cognitive impairments. Therefore, our data suggest
hat the possible beneﬁcial consequences of early life enrichment
oward cognitional skills do not last until adulthood in the LDLr−/−
ice.
. ConclusionsIn conclusion, here we showed that both pharmacological
probucol) and non-pharmacological (physical exercise) agents are
uccessful strategies to decrease total and non-HDL plasma choles-
erol in LDLr−/− mice, an experimental model of FH. In addition, we
[ Letters 541 (2013) 193– 198 197
showed that exercise, but not probucol, mitigated spatial mem-
ory deﬁcits of LDLr−/− mice. Collectively, our results emphasize the
advantages of exercise, in comparison to lipid-lowering drugs, for
management of cognitive deﬁcits associated with FH.
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